![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
NL Diehl, JC Kermode and SM Shreeve
Department of Pharmacology, College of Medicine, University of Vermont, Burlington 05405, USA.
Although vasoactive intestinal peptide (VIP) exerts many of its effects through stimulation of adenylyl cyclase, there is increasing evidence that other signaling pathways may contribute to its action. The role of inhibitory G proteins (Gi) in VIP-mediated signaling in the lung was assessed by a combination of equilibrium-binding and covalent cross- linking studies. Pertussis toxin treatment of rat lung membranes reduced the high affinity binding of 125I-VIP, implicating a member of the Gi family in signaling from the VIP receptor. The particular G protein involved was identified as Gi3 through capture of a VIP/receptor/ Gi3 ternary complex by covalent cross-linking. There was a progressive rise with increasing VIP concentration in formation of the complex reported by the cross-linking strategy. Guanine nucleotides and an anti-G alpha i3 antiserum suppressed formation of the VIP/receptor/Gi3 ternary complex, demonstrating its functional nature in native lung membranes. Inhibition of high affinity 125I-VIP binding by the anti-G alpha i3 antiserum verified this functionality. Taken together, these data suggest that receptor/ Gi3 coupling makes a significant contribution to VIP-mediated signaling in the lung and illustrate the value of covalent cross-linking as a strategy to define receptor/G protein complexes that arise under conditions in which the stoichiometry and microdomains of the native cell membrane are preserved.
This article has been cited by other articles:
|
|
 |
|
  W.-C. Chung and J. C. Kermode Suramin Disrupts Receptor-G Protein Coupling by Blocking Association of G Protein {alpha} and {beta}{gamma} Subunits J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 191 - 198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. MacKenzie, E. M. Lutz, M. S. Johnson, D. N. Robertson, P. J. Holland, and R. Mitchell Mechanisms of Phospholipase C Activation by the Vasoactive Intestinal Polypeptide/Pituitary Adenylate Cyclase-Activating Polypeptide Type 2 Receptor Endocrinology, March 1, 2001; 142(3): 1209 - 1217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Haug and J. F. Storm Protein Kinase A Mediates the Modulation of the Slow Ca2+-Dependent K+ Current, IsAHP, by the Neuropeptides CRF, VIP, and CGRP in Hippocampal Pyramidal Neurons J Neurophysiol, April 1, 2000; 83(4): 2071 - 2079. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Thorin, M. A. Shatos, S. M. Shreeve, C. L. Walters, J. A. Bevan, and W. G. Mayhan Human Vascular Endothelium Heterogeneity: A Comparative Study of Cerebral and Peripheral Cultured Vascular Endothelial Cells Stroke, February 1, 1997; 28(2): 375 - 381. [Abstract] [Full Text]
|
|
|
|
|
|
S. M. Shreeve, M. A. Shatos, and E. Thorin {alpha}-Thrombin Upregulates G{alpha}i3 in Human Vascular Endothelial Cells Stroke, December 1, 1996; 27(12): 2211 - 2215. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
